BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11938494)

  • 1. The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder.
    Kallijärvi J; Avela K; Lipsanen-Nyman M; Ulmanen I; Lehesjoki AE
    Am J Hum Genet; 2002 May; 70(5):1215-28. PubMed ID: 11938494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in the TRIM37 gene in Mulibrey Nanism.
    Hämäläinen RH; Avela K; Lambert JA; Kallijärvi J; Eyaid W; Gronau J; Ignaszewski AP; McFadden D; Sorge G; Lipsanen-Nyman M; Lehesjoki AE
    Hum Mutat; 2004 May; 23(5):522. PubMed ID: 15108285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM37, a novel E3 ligase for PEX5-mediated peroxisomal matrix protein import.
    Wang W; Xia ZJ; Farré JC; Subramani S
    J Cell Biol; 2017 Sep; 216(9):2843-2858. PubMed ID: 28724525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity.
    Jagiello P; Hammans C; Wieczorek S; Arning L; Stefanski A; Strehl H; Epplen JT; Gencik M
    Hum Mutat; 2003 Jun; 21(6):630-5. PubMed ID: 12754710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase.
    Kallijärvi J; Lahtinen U; Hämäläinen R; Lipsanen-Nyman M; Palvimo JJ; Lehesjoki AE
    Exp Cell Res; 2005 Aug; 308(1):146-55. PubMed ID: 15885686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis.
    Weller S; Cajigas I; Morrell J; Obie C; Steel G; Gould SJ; Valle D
    Am J Hum Genet; 2005 Jun; 76(6):987-1007. PubMed ID: 15858711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism.
    Brigant B; Metzinger-Le Meuth V; Rochette J; Metzinger L
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30586926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Arabidopsis peroxisomal targeting signal type 2 receptor PEX7 is necessary for peroxisome function and dependent on PEX5.
    Woodward AW; Bartel B
    Mol Biol Cell; 2005 Feb; 16(2):573-83. PubMed ID: 15548601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumor and novel TRIM37 mutations in an Australian patient with mulibrey nanism.
    Hämäläinen RH; Mowat D; Gabbett MT; O'brien TA; Kallijärvi J; Lehesjoki AE
    Clin Genet; 2006 Dec; 70(6):473-9. PubMed ID: 17100991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecological tumors in Mulibrey nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fibrothecomas.
    Karlberg S; Lipsanen-Nyman M; Lassus H; Kallijärvi J; Lehesjoki AE; Butzow R
    Mod Pathol; 2009 Apr; 22(4):570-8. PubMed ID: 19329943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue expression of the mulibrey nanism-associated Trim37 protein in embryonic and adult mouse tissues.
    Kallijärvi J; Hämäläinen RH; Karlberg N; Sainio K; Lehesjoki AE
    Histochem Cell Biol; 2006 Sep; 126(3):325-34. PubMed ID: 16514549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mulibrey nanism--a novel peroxisomal disorder.
    Kallijärvi J; Lehesjoki AE; Lipsanen-Nyman M
    Adv Exp Med Biol; 2003; 544():31-7. PubMed ID: 14713209
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotype-phenotype correlation in PEX5-deficient peroxisome biogenesis defective cell lines.
    Ebberink MS; Mooyer PA; Koster J; Dekker CJ; Eyskens FJ; Dionisi-Vici C; Clayton PT; Barth PG; Wanders RJ; Waterham HR
    Hum Mutat; 2009 Jan; 30(1):93-8. PubMed ID: 18712838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trim37-deficient mice recapitulate several features of the multi-organ disorder Mulibrey nanism.
    Kettunen KM; Karikoski R; Hämäläinen RH; Toivonen TT; Antonenkov VD; Kulesskaya N; Voikar V; Hölttä-Vuori M; Ikonen E; Sainio K; Jalanko A; Karlberg S; Karlberg N; Lipsanen-Nyman M; Toppari J; Jauhiainen M; Hiltunen JK; Jalanko H; Lehesjoki AE
    Biol Open; 2016 May; 5(5):584-95. PubMed ID: 27044324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid isolation and characterization of CHO mutants deficient in peroxisome biogenesis using the peroxisomal forms of fluorescent proteins.
    Ito M; Ito R; Huang Y; Miura S; Imamura A; Suzuki Y; Shimozawa N
    Biochim Biophys Acta; 2000 Apr; 1496(2-3):232-42. PubMed ID: 10771091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in TRIM37 is associated with mulibrey nanism in a Turkish boy.
    Doğancı T; Yüksel Konuk BE; Alpan N; Konuk O; Hämäläinen RH; Lehesjoki AE; Tekin M
    Clin Dysmorphol; 2007 Jul; 16(3):173-176. PubMed ID: 17551331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import.
    Chang CC; Warren DS; Sacksteder KA; Gould SJ
    J Cell Biol; 1999 Nov; 147(4):761-74. PubMed ID: 10562279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the mulibrey nanism-associated TRIM37 gene: transcription initiation, promoter region and alternative splicing.
    Hämäläinen RH; Joensuu T; Kallijärvi J; Lehesjoki AE
    Gene; 2006 Jan; 366(1):180-8. PubMed ID: 16310976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisomal AAA ATPase complex prevents pexophagy and development of peroxisome biogenesis disorders.
    Law KB; Bronte-Tinkew D; Di Pietro E; Snowden A; Jones RO; Moser A; Brumell JH; Braverman N; Kim PK
    Autophagy; 2017 May; 13(5):868-884. PubMed ID: 28521612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance.
    Nguyen T; Bjorkman J; Paton BC; Crane DI
    J Cell Sci; 2006 Feb; 119(Pt 4):636-45. PubMed ID: 16449325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.